Advances in psychopharmacology and the development of new antipsychotic med
ications may represent increased opportunities for psychologists to provide
expanded psychosocial services to patients with schizophrenia The new agen
ts, referred to as the atypical antipsychotics, are as efficacious as the o
lder conventional antipsychotics but demonstrate a mole favorable side effe
ct profile. Preliminary data suggest improvements in cognitive deficits and
negative symptoms typically associated with schizophrenia, which may enhan
ce long-term outcome. Psychologists may be increasingly called on to provid
e psychosocial services to this population, thereby requiring that they hav
e a sound working knowledge of the pharmacological and psychological proper
ties of these agents.